Effects of methylation and imprinting expression of Insulin-like growth factor 2 gene in gastric cancer

被引:1
作者
Sun, Jiting [1 ]
Shu, Jun [1 ,2 ]
Shi, Duo [1 ]
Liu, Wen [1 ]
Zhang, Yan [1 ,3 ]
Luo, Bing [1 ]
机构
[1] Qingdao Univ, Sch Basic Med, Dept Pathogen Biol, Qingdao, Shandong, Peoples R China
[2] Fudan Univ, Sch Basic Med Sci, Key Lab Med Mol Virol MOE NHC CAMS, Shanghai, Peoples R China
[3] Zibo Cent Hosp, Dept Clin Lab, Zibo, Shandong, Peoples R China
关键词
Epstein-barr virus; insulin-like growth factor 2; genomic imprinting; DNA methylation; gastric cancer; EPSTEIN-BARR-VIRUS; IGF2; H19; DNA;
D O I
10.3233/CBM-230105
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Epstein-Barr virus (EBV)-associated gastric cancer (EBVaGC) is a common malignant tumor associated with EBV infection. Insulin-like growth factor 2 (IGF2) is an imprinted gene and a key protein that regulates growth, especially during normal fetal development. Loss of imprinting (LOI), is a common epigenetic anomaly in a variety of human cancers. However, the promoter methylation, imprinting status and function of IGF2 gene in GC are unclear. OBJECTIVE: To explore the role of IGF2 in the occurrence and development of gastric cancer. METHODS: The biological function of IGF2 in gastric cancer was investigated by Transwell, wound healing, CCK-8 and flow cytometry assays. IGF2 imprinting status and gene promoter methylation in gastric cancer tissues were detected by PCR-RFLP and BGS. RESULTS: The results showed that the expression of IGF2 was higher in GC tissues than adjacent tissues. IGF2 gene promoter methylation and LOI were significantly higher in EBVaGC tissues than in EBV-negative gastric cancer (EBVnGC) tissues. The high expression of IGF2 in gastric cancer can promote the migration and proliferation of gastric cancer cells. CONCLUSION: Our data suggest that IGF2 is involved in the occurrence and development of gastric cancer. Targeting IGF2 may be a potential therapeutic target for gastric cancer.
引用
收藏
页码:355 / 366
页数:12
相关论文
共 26 条
  • [1] Identification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma
    Abril-Fornaguera, Jordi
    Torrens, Laura
    Andreu-Oller, Carmen
    Carrillo-Reixach, Juan
    Rialdi, Alex
    Balaseviciute, Ugne
    Pinyol, Roser
    Montironi, Carla
    Haber, Philipp K.
    Del Rio-Alvarez, Alvaro
    Domingo-Sabat, Montserrat
    Royo, Laura
    Akers, Nicholas K.
    Willoughby, Catherine E.
    Peix, Judit
    Torres-Martin, Miguel
    Puigvehi, Marc
    Cairo, Stefano
    Childs, Margaret
    Maibach, Rudolf
    Alaggio, Rita
    Czauderna, Piotr
    Morland, Bruce
    Losic, Bojan
    Mazzaferro, Vincenzo
    Guccione, Ernesto
    Sia, Daniela
    Armengol, Carolina
    Llovet, Josep M.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2023, 22 (04) : 485 - 498
  • [2] Understanding the Mechanism of Insulin and Insulin-Like Growth Factor (IGF) Receptor Activation by IGF-II
    Alvino, Clair L.
    Ong, Shee Chee
    McNeil, Kerrie A.
    Delaine, Carlie
    Booker, Grant W.
    Wallace, John C.
    Forbes, Briony E.
    [J]. PLOS ONE, 2011, 6 (11):
  • [3] Epigenetic Regulation of Viral Biological Processes
    Balakrishnan, Lata
    Milavetz, Barry
    [J]. VIRUSES-BASEL, 2017, 9 (11):
  • [4] Comprehensive molecular characterization of gastric adenocarcinoma
    Bass, Adam J.
    Thorsson, Vesteinn
    Shmulevich, Ilya
    Reynolds, Sheila M.
    Miller, Michael
    Bernard, Brady
    Hinoue, Toshinori
    Laird, Peter W.
    Curtis, Christina
    Shen, Hui
    Weisenberger, Daniel J.
    Schultz, Nikolaus
    Shen, Ronglai
    Weinhold, Nils
    Keiser, David P.
    Bowlby, Reanne
    Sipahimalani, Payal
    Cherniack, Andrew D.
    Getz, Gad
    Liu, Yingchun
    Noble, Michael S.
    Pedamallu, Chandra
    Sougnez, Carrie
    Taylor-Weiner, Amaro
    Akbani, Rehan
    Lee, Ju-Seog
    Liu, Wenbin
    Mills, Gordon B.
    Yang, Da
    Zhang, Wei
    Pantazi, Angeliki
    Parfenov, Michael
    Gulley, Margaret
    Piazuelo, M. Blanca
    Schneider, Barbara G.
    Kim, Jihun
    Boussioutas, Alex
    Sheth, Margi
    Demchok, John A.
    Rabkin, Charles S.
    Willis, Joseph E.
    Ng, Sam
    Garman, Katherine
    Beer, David G.
    Pennathur, Arjun
    Raphael, Benjamin J.
    Wu, Hsin-Ta
    Odze, Robert
    Kim, Hark K.
    Bowen, Jay
    [J]. NATURE, 2014, 513 (7517) : 202 - 209
  • [5] PARENTAL IMPRINTING OF THE MOUSE INSULIN-LIKE GROWTH FACTOR-II GENE
    DECHIARA, TM
    ROBERTSON, EJ
    EFSTRATIADIS, A
    [J]. CELL, 1991, 64 (04) : 849 - 859
  • [6] IGF2 imprinting loss promotes cancer expression
    Fenner, Annette
    [J]. NATURE REVIEWS UROLOGY, 2017, 14 (10) : 583 - 583
  • [7] Gao TY, 2020, AGING-US, V12, P21236, DOI 10.18632/aging.103837
  • [8] Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer
    Hamilton, Nalo
    Austin, David
    Marquez-Garban, Diana
    Sanchez, Rudy
    Chau, Brittney
    Foos, Kay
    Wu, Yanyuan
    Vadgama, Jaydutt
    Pietras, Richard
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (11):
  • [9] Epstein-Barr Virus (EBV)-associated Gastric Carcinoma
    Iizasa, Hisashi
    Nanbo, Asuka
    Nishikawa, Jun
    Jinushi, Masahisa
    Yoshiyama, Hironori
    [J]. VIRUSES-BASEL, 2012, 4 (12): : 3420 - 3439
  • [10] Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.21492, 10.3322/caac.20115]